- Home
- BDRX vs ADN Comparison
BDRX vs ADN Comparison
Compare BDRX & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- ADN
- Stock Information
- Founded
- BDRX 2000
- ADN 2006
- Country
- BDRX United Kingdom
- ADN United States
- Employees
- BDRX 13
- ADN N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- ADN Power Generation
- Sector
- BDRX Health Care
- ADN Utilities
- Exchange
- BDRX Nasdaq
- ADN Nasdaq
- Market Cap
- BDRX 3.9M
- ADN 10.0M
- IPO Year
- BDRX N/A
- ADN N/A
- Fundamental
- Price
- BDRX $6.99
- ADN $3.44
- Analyst Decision
- BDRX
- ADN
- Analyst Count
- BDRX 0
- ADN 0
- Target Price
- BDRX N/A
- ADN N/A
- AVG Volume (30 Days)
- BDRX 53.1K
- ADN 802.6K
- Earning Date
- BDRX 09-23-2025
- ADN 08-12-2025
- Dividend Yield
- BDRX N/A
- ADN N/A
- EPS Growth
- BDRX N/A
- ADN N/A
- EPS
- BDRX N/A
- ADN N/A
- Revenue
- BDRX N/A
- ADN $115,000.00
- Revenue This Year
- BDRX N/A
- ADN $6,528.51
- Revenue Next Year
- BDRX N/A
- ADN N/A
- P/E Ratio
- BDRX N/A
- ADN N/A
- Revenue Growth
- BDRX N/A
- ADN N/A
- 52 Week Low
- BDRX $5.00
- ADN $1.71
- 52 Week High
- BDRX $108.90
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- BDRX 59.97
- ADN 51.04
- Support Level
- BDRX $5.81
- ADN $2.75
- Resistance Level
- BDRX $6.47
- ADN $3.34
- Average True Range (ATR)
- BDRX 0.48
- ADN 0.39
- MACD
- BDRX 0.23
- ADN -0.11
- Stochastic Oscillator
- BDRX 95.06
- ADN 27.82
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.